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1. Introduction 
Human leucocytes contain several enzymes which 
participate in the degradation of collagen [l-3]. The 
cleavage of the tropocollagen molecule, (preferen- 
tially type I collagen), is initiated by a true collagen- 
ase splitting the collagen molecule into two distinct 
fragments [l]. Since the initial demonstration of col- 
lagenolytic activity in leucocytes [ 11, it has been 
shown that the enzyme exists in both active and 
latent forms in extracts of human leucocytes [2]. The 
latent collagenase can be activated by other active 
neutral proteases [4-S] and recently cathepsin G, a 
chymotrypsin-like enzyme, isolated from human 
leucocytes has been shown to be capable of activating 
the latent enzyme [7]. In previous years proteolytic 
enzymes have been used by many groups to activate 
the latent collagenases obtained from a variety of 
other tissues and a multistep scheme has been pro- 
posed for collagenase activation by limited proteoly 
sis [8-l 11. There also exists evidence to support the 
hypothesis that activation of the latent enzyme takes 
place through the removal of an inhibitor from an 
enzyme-inhibitor complex [2,5,6,1 l-131. 
In this paper we wish to report on the isolation of 
a latent collagenase from human leucocytes and its 
activation to active collagenase by enzymically active 
and non-active agents, that remove an inhibitor pro- 
tein (24 000 M,) from the latent enzyme which is 
capable of inhibiting the active enzyme. 
2. Materials and methods 
Collagenolytic activity was measured by a method 
employing the use of 4.phenylspiro [furan-2(3 H),l- 
phthalan] 3,3’dione, (fluorescamine) (Sigma Chemi- 
ElsevierfNorth-Holland Biomedical Press 
cal Co., St Louis, MO). Fluorescamine was used to 
measure the proteolytic activity of collagenase 
against neutral salt-soluble rat skin (NSS) collagen 
solution by the increase in fluorescence emission per 
unit time. NSS collagen solutions were prepared 
according to a modification of the method in [ 141. 
Various amounts (lo-100 111) of latent collagenase 
extracts were added to 0.2% NSS collagen solutions 
(200 ~1). The final reaction volume was made up to 
400 ~1 by addition of either 0.1 M Tris/HCl; 50 mM 
CaClz (pH 7.4) or by addition of one of the activators 
(0.1 mg/ml). On addition of latent collagenase xtract 
to the collagen solution a 20 ~1 aliquot of the reac- 
tion mixture was taken. This measurement provided 
a zero time reading. After the incubation period 
(3 h at 3O’C) was over a further 20 /.d aliquot was 
taken. These aliquots were added to 0.2 M phosphate 
buffer at pH 6.8 (4.0 ml). Then fluorescamine reagent 
(2 ml, 0.1 mg/ml) in acetone was added to the phos- 
phate buffer and the fluorescence emissions at 475 nm 
were measured employing an excitation wavelength 
of 390 mn on a JY 3 D spectrofluorinieter (Instru- 
ments SA GmbH). The difference between the zero 
time and the 3 h fluorescence emission readings gave 
a qualitative measurement of collagenase activity. 
The assay system was quantified by determining a 
calibration curve relating the fluorescence emission 
readings to an equivalent concentration of Liso- 
leucyl-Lalanylglycine ethyl ester (a personal gift 
from M/s G. Kay, The Queen’s University of Belfast, 
N. Ireland). The solution was 100 PM (3.21 mg/l) 
in 0.2 M phosphate buffer (pH 6.8). It was calculated 
that 1 .O E.~M of amino groups formed by cleavage of 
the collagen molecule will react with fluorescamine 
to give 52.4 units of fluorescence. This fluorescence 
emission would be equivalent to the cleavage of 
6.024 X 10” bonds. Hence one may calculate the 
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number of bonds cleaved per unit increase in fluores- 
cence as: 
6.024 X IO” 
‘= 1.15 X 1016 bonds 
52.4 
Viscometric assay of extracts was carried out using an 
automatic viscometer (Macartney, Blumsom and 
Elmore, in preparation). 
The preparation of leucocytes and granule extracts 
was based on a modification of the method in [3]. 
Activation of the latent collagenase with trypsin 
was done as in [8]. Activation with other proteolytic 
enzymes, the inhibited proteolytic enzymes (see 
table l), the thiol blocking compounds cystine and 
glutathione insulin and the organomercurial com- 
pound p-chloromercuribenzoate was done with 10 a 
activator/SO ~1 extract. 
TLCK-trypsin was prepared as described [15] 
from pancreatic trypsin (Sigma Chemical Co., 
St Louis MO). DFP and PMSF inhibited cathepsin G 
were prepared by incubating cathepsin G (a gift from 
Bayer AG) with the corresponding inactivator at a ratio 
of enzyme:inhibitor of 1 :lOOO at 4°C for 4 h. All inhib- 
ited proteolytic enzymes were shown to possess no 
further proteolytic activity. Commercial preparations 
of mixtures of unresolved Q, p, 71 as well as 90% 
fl-trypsin and TLCK-trypsin were pre-incubated with 
cysteine for 1 h; collagenase was pretreated for 3 h 
with cysteine or reduced glutathione. l79,203di- 
S-carboxymethyl-trypsinogen and l79,203diS- 
carboxymethyl-trypsin were kindly provided by 
A. Light, Purdue, Lafayette. 
Partial purification of the latent collagenase and 
of the active enzyme was carried out on Sephadex 
G-75 Superfine (Deutsche Pharmacia GmbH). The gel 
filtration column was calibrated for molecular weight 
determination according to [ 161, with myoglobin 
(17.8 X 103); chymotrypsin (25 X 103); egg albumin 
(45 X 103);liver albumin (65 X 103);aldolase (147 X 103). 
Table 1 
Activation of the latent enzyme by enzymes, inhibited enzymes, cystine, oxidised 
glutathione and partly cysteine reduced proteins 
Activator Bonds cleaved Relative % 
activation 
Oxidised glutathione 
Cystine 
Insulin 
Trypsinogen 
TLCK-trypsin control 
TLCK-trypsin cysteine treated 
Trypsin-cysteine treated 
p-Trypsht 
di&carboxymethyl-trypainogen 
diS-carboxymethyl-trypsin 
Unactivated controlb 
Trasylol 
2.795 X 10” 
2.783 X lo’* 
2.348 x 10’s 
2.043 X IO’* 
2.783 x IO” 
3.335 x 10” 
3.795 x 10” 
9.200 X 10” 
0 
3.450 x 1Ol6 
2.875 X 10” 
0 
100 
99.6 
84.0 
73.1 
99.6 
11.9 
13.5 
32.9 
0 
1.2 
10.3 
0 
Cathepsin Ga 1.208 X lo’* - 
DFP-cathepsin G 9.660 x 10” 100 
PMSF-cathepsin G 8.860 x 10” 92.0 
Pancreas kallikrem 5.371 x 10” 56.0 
Trypsin control 8.050 X 10” 83.0 
Unactivated controlb 2.530 x 10” 26.0 
a Due to the additional proteolytic activities of cathepsin G, or trypsin in the 
activation mixtures the collagenolytic activity of the latent enzyme after 
activation by inactive DFP-cathepshr G, or oxidised glutathione was chosen as 
100% standard 
b The latent enzyme preparations were contaminated with 10% and 26% active 
enzyme, respectively 
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Dete~inat~on of the sul~ydryl group concentra- 
tion was carried out by the method of Ellman [ 171 
with 55’.dithiobis(2.nitrobenzoic a id) (DTNB) 
(Sigma Chemical Co., St Louis MO). 
3. Results 
The concentrated extracts from the nuclear and 
the crude granule preparations which showed signifi- 
cant collagenolytic activity were pooled and then sub- 
jected to gel f~tration on a Sephadex G-75 Superfine 
column (fgl), pre-calibrated with standard proteins 
(see section 2). Eluted fractions were collected in 
10 ml aliquots and these were assayed for collagen- 
olytic activity (fgl). The latent enzyme luted with 
a maximum activity at 80 ml corresponding toMr 
-80 000. A preparation of latent enzyme devoid 
of any collagenolytic activity could be collected by 
two (or more) repeated gel filtrations of the latent 
80 000 &fr fraction. The active enzyme eluted with 
a maximum activity at 100 ml corresponding toMr 
65 000 and could be further activated by addition 
of zinc salt. 
Activation of the crude enzyme concentrate by 
disulfide containing activators, prior to gel filtration, 
resulted in the collagenolytic activity being eluted at 
a molecular weight corresponding toMr 60 OOO- 
65 000. Further activation produced no further sig 
r&cant increase in the coBagenolytic activity (fig.2). 
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Fig-l. Effhzeut profile of Iatent human leucocyte collagenase 
on a column (1 cm X 90 cm) of Sephadex G-75 Supefme 
equilibrated and eluted with 0.1 M Tris/HCl (pH 7.4), 50 mM 
in CaCl,. Flow rate 10 ml/h. Fraction volume 10 ml. 
0.26 - 
Fig.2. Effluent profile of cystine-activated human leucocyte 
collagenase from a column (1 cm X 90 cm) of Sephadex G-75 
Superfme equilibrated and eluted with 0.1 M Tris/HCl 
(pH 7.4), SO mM in CaCl,. Flow rate 10 ml/h. Fraction vol- 
ume 10 ml. 
Inhibitor vol tpll - 
Fig.3. Titration curve of human leucocyte collagenase with 
human leuoocyte collagenase inhibitoi isolated from the 
latent enzyme (see fig.2). When 200 ~1 i~bitor (22.9 mg 
prote~/ml) were added to 100 ~1 enzyme (7.2 mg ~~te~/ml) 
the inhibitor was taken to represent 100% relative inhibition. 
For test conditions, see section 2. 
A second fraction in the gel filtration corresponded 
to Mr 24 000 (fig.2). This i~bitor fraction was 
capable of completely inhibiting the collagenolytic 
activity when titrated with the 60 000-65 000 L&f, 
enzyme fraction (fig.3). The inhibitor:enzyme molar 
combining ratio was estimated on the basis of protein 
determinations of the partially purified proteins 
(estimate 80-90% and 70-80% purity, respectively), 
assuming Mr 24 000 and 65 000 for the inhibitor 
and collagenase, respectively. This value varied 
between 1 :l and 1:2. The active collagenase obtained 
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Activator [Cystlne OLmMIpt - 
Fig.4. Activation curve of human leucocyte latent collagenase 
(100 r.11) obtained by cystine (0.4 mM in 0.1 M Tris/HCl 
buffer (pH 7.4) and 50 mM in CaC1,). Collagenolytic activity 
was determined by the fluorescamine method (see section 2). 
was able to reduce the viscosity of a 0.2% NSS col- 
lagen solution by -40%. 
It was possible to activate collagenolytic activity 
in crude extracts using inhibited proteolytic enzymes, 
cystine, glutathione, insulin and p-chloromercuri- 
benzoate (fig.4, table 1). No activation of the latent 
enzyme could be achieved with either elastase from 
pig pancreas or from human polymorphonuclear 
leucocytes, nor with commercial trypsin or TLCK- 
trypsin in both pretreated for 1 h with cysteine. Only 
slight activation occurred with 90% bovine fl-trypsin. 
Neither could activation be achieved with 179,203-di- 
S-carboxymethyl-trypsinogen or 179,203-diS- 
carboxymethyl-trypsin. 
The activity of the active collagenase could be 
abolished by a 3 h pretreatment with either cysteine 
or reduced glutathione. All investigations on the 
inhibitor were performed with material isolated from 
Table 2 
Inhibitor activity of 24 000 Afr inhibitor against active 
collagenase after 1 h preincubation of the inhibitor with 
oxidised glutathione 
Control 1.73 x 10” 100 
Inhibitor control 4.60 X 10” 2Sa 
Inhibitor + glutathione 1.81 x lOI 100 
a Amount of inhibitor added was insufficient to produce 
complete inhibition 
Tube contents Bonds cleaved Relative % Activation 
partially purified latent enzyme (fii.1). The 80 000 
Mr fraction was isolated, activated by cystine and 
subjected to a second gel filtration step to give active 
enzyme and the 24 000 low M, fraction (fig.2) repre- 
senting -80% pure inhibitor. The inhibiting activity 
of the separated inhibitor could be abolished by a 1 h 
pretreatment with cystine, or oxidised glutathione 
(table 2). 
The inhibitor was shown to contain a sulfhydryl 
group titratable with Ellman’s reagent. From the pro- 
tein concentration of the inhibitor (1.2 X 10” M, 
Folin determination) and the sulfhydryl group con- 
centration (9.6 X 1Od M, Elhnan determination) the 
number of sulfhydryl groups per molecule of inhibi- 
tor was calculated to be nearly one on the basis of 
M, 24 000 for the inhibitor. The inactivation of the 
inhibitor by cystine and/or oxidised glutathione can 
(easily) be explained by a thiol-disulfide interchange 
reaction (see scheme 1 and section 4). 
4. Discussion 
The results indicate that a latent form of a true 
collagenase devoid of activity can be obtained from 
human polymorphonuclear (PMN) leucocytes. This 
latent collagenase can be activated by the activators 
discussed above (see table 1) to give the active form 
of the enzyme and an inhibitor separable by gel fil- 
tration. Partial inactivation of the collagenase by 
removal of the complex ligand zinc during this sepa- 
ration process can be reversed by incubation with 
zinc salts (table 1). In several of the PMN leucocyte 
preparations the active enzyme was also present in 
varying amounts. However this active portion could 
be completely removed by repeated gel filtration to 
yield only inactive latent enzyme. It could therefore 
be reasonably concluded that the observation of 
‘already active enzyme’ in several of the crude PMN 
leucocyte preparations, prior to activation, is an 
artifactual result, since activation of a certain per- 
centage of the latent enzyme may have taken place 
during the isolation procedure, e.g., via activation by 
cathepsin G demonstrated to be present in the 
extracts, or by oxidised glutathione present in the 
granules [18]. 
In contrast to other workers [2,19] our results 
indicate that the latent enzyme is present in the form 
of an enzyme-inhibitor complex, as has been previ- 
ously suggested [20], and is not activated by a limited 
proteolytic process. The observed activation of the 
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latent enzyme seems to be due to removal of an 
inhibitor from the complex. The inhibitor can be 
isolated and contains an essential sulfhydryl group. 
It can be used in a titration experiment to abolish 
the collagenolytic activity and to restore the form of 
the inactive latent enzyme. This favours a mechanism 
of inhibition via formation of a disulfide bridge 
between enzyme and inhibitor. In this complex the 
active sulfhydryl group of the inhibitor may interact 
in a disulfide exchange reaction with one of the sur- 
face exposed isulfide bridges in the substrate binding 
pocket of the enzyme thus blocking the access of 
substrate. In reaction with trypsinogen the disulfrde 
bridge Cys 179~Cys 203 in proximity to the reactive 
site [21] is the most favourable on the basis of the 
selective reduction experiments in [22]. This is sup- 
ported by the failure to activate latent enzyme by tryp- 
sinogen preincubated with cysteine, or by 179,203-d& 
S-carboxymethyl-trypsinogen or by l79,203diS- 
carboxymethyl-trypsin a d the fact that trypsin is 
inhibited after activation of the latent enzyme. 
This mechanistic view is further strengthened by
the findings that (a) the inhibitor contains one sulf- 
hydryl group per molecule and could be inactivated 
by preincubation with oxidised glutathione and 
reactivated by treatment with sodium borohydride 
(scheme l), and (b) that the protein activators (tryp- 
sininogen commercial nd TLCK-trypsin) were unable 
to activate the latent enzyme after pretreatment with 
cysteine (table 1). The proposed mechanism issup 
ported by the inactivation of the collagenase by pre- 
treatment with either cysteine or reduced gluta- 
thione. The activation-inactivation mechanism is
shown schematically below :
(a) CYS 
I + 
CYS 
Cystine 
( b) CYS 
I + 
CYS 
Cystine 
(c 1 CYS 
I + 
CYS 
2 HS-Inh. _ 
Cystine Inhibitor 
,S-S-Inh. Activation 
4 
E Z E:,i + CyS-S- Inh. + CySH 
‘SH 
Latent 
enzyme 
Inactivation 3 
Active 
enzyme 
Cysteine- 
Inhibitor 
complex 
Cysteine 
HS-Inh. _ 
In h i bitor 
(d) CyS-S-Inh. 
Na(BH4, _ 
CyS-S-Inh. 
Cysteine- 
Inhi bitor 
complex 
S-Inh. 
I + 
S-Inh. 
Oxidised 
Inhi bitor 
Inh.-SH + 
+ CySH 
Cysteinr 
2 CySH 
Cysteine 
CySH 
Cysteine- 
Inhibitor 
complex 
Inhibitor Cysteine 
Activation -inactivation scheme 
331 
Volume 119, number 2 FEBS LETTERS October 1980 
A similar mechanism of enzyme-inhibitor inter- 
action has been proposed in [23] for the interaction 
of the basic bovine inhibitor (Kunitz, i.e., Trasylol@) 
and bovine trypsins, but that has been proven to be 
wrong on the basis of the X-ray crystallographic 
investigations of the complex [24]. In [25,26] a 
similar mechanism was proposed to explain the inter- 
action of a trypsindependent neutral protease and 
its inhibitor present in malignant tissue. 
It is also interesting to note that active, or inactive 
cathepsin G as well as oxidised glutathione and insu- 
lin activate latent collagenase effectively, a fact which 
may be of physiological significance in the cell or in 
inflamed tissue. 
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